Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?

Giraud, Eline L; de Jong, Loek A W; van den Hombergh, Erik; Kaal, Suzanne E J; van Erp, Nielka P; Desar, Ingrid M E

Giraud, Eline L; de Jong, Loek A W; van den Hombergh, Erik; Kaal, Suzanne E J; van Erp, Nielka P; Desar, Ingrid M E.

Afiliação

Giraud EL; Radboud University Medical Centre, Department of Pharmacy, 6500 HB Nijmegen, The Netherlands.
de Jong LAW; Radboud University Medical Centre, Department of Pharmacy, 6500 HB Nijmegen, The Netherlands.
van den Hombergh E; Radboud University Medical Centre, Department of Pharmacy, 6500 HB Nijmegen, The Netherlands.
Kaal SEJ; Radboud University Medical Centre, Department of Medical Oncology, 6500 HB Nijmegen, The Netherlands.
van Erp NP; Radboud University Medical Centre, Department of Pharmacy, 6500 HB Nijmegen, The Netherlands.
Desar IME; Radboud University Medical Centre, Department of Medical Oncology, 6500 HB Nijmegen, The Netherlands.

Cancers (Basel) ; 15(11)2023 May 23.

Article em En | MEDLINE | ID: mdl-37296838

Palavras-chave

GIST; gastrointestinal stromal tumours; imatinib; neoadjuvant treatment; pathological treatment response; tumoral drug concentrations; tumour drug concentrations; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda